
Beckman Coulter Life Sciences and Watchmaker Genomics have announced that they have entered into a collaborative partnership with the aim …

Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has completed the redevelopment and expansion …

Scientists studying the gene editing technology CRISPR-Cas9 have discovered the technique appears to frequently cause genetic damage that may slip …

A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …

China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject, suffering from metastatic lung cancer. This …

The genetic testing firm 23andMe is seeking to raise $150 million in order to move into its own drug development …

The Google-backed DNA test company 23andMe has announced plans to start using genetic data to design new drugs. In recent …

Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …

Genentech has thrown its weight behind the contentious DNA testing company 23andMe, by agreeing a deal to buy the genomic …

The MHRA has approved a controversial genetic test for the UK – despite it being banned by the US FDA. …

Google is to collect samples of human tissue from thousands of people as part of an experiment that could help …

Gene analysis specialist Illumina has been chosen to deliver a project to sequence 100,000 whole genomes from NHS patients by …

AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer. This …

Sanofi has agreed to produce genetic compounds developed by German biotech Isarna Therepeutics to accelerate their progress to the clinical …

The Department of Health has launched a £10 million competition to fund businesses working on new technology which will map …